Manufacturer
Merck Sharp & Dohme NDC Codes
Finished products listed with the FDA under labeler names that contain “Merck Sharp & Dohme”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sivextrotedizolid phosphate | Tedizolid phosphate 200 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 67919-040 |
| Sivextrotedizolid phosphate | Tedizolid phosphate 200 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 67919-041 |
| Steglatroertugliflozin | Ertugliflozin pidolate 5 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5363 |
| Steglatroertugliflozin | Ertugliflozin pidolate 15 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5364 |
| Steglujanertugliflozin and sitagliptin | Ertugliflozin pidolate 5 mg/1; Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5367 |
| Steglujanertugliflozin and sitagliptin | Ertugliflozin pidolate 15 mg/1; Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5368 |
| Sterile Diluentsterile water | Water .7 mL/.7mL | InjectionIntramuscular, Subcutaneous | Merck Sharp & Dohme LLC | 0006-4175 |
| Sterile Diluentsterile water | Water .7 mL/.7mL | InjectionIntramuscular, Subcutaneous | Merck Sharp & Dohme LLC | 0006-4309 |
| Stromectolivermectin | Ivermectin 3 mg/1 | TabletOral | Merck Sharp & Dohme LLC | 0006-0032 |
| Temodartemozolomide | Temozolomide 100 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0085-1366 |
| Temodartemozolomide | Temozolomide 2.5 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 0085-1381 |
| Temodartemozolomide | Temozolomide 250 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0085-1417 |
| Temodartemozolomide | Temozolomide 140 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0085-1425 |
| Temodartemozolomide | Temozolomide 180 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0085-1430 |
| Temodartemozolomide | Temozolomide 20 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0085-1519 |
| Temodartemozolomide | Temozolomide 5 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0085-3004 |
| Tice Bcgbacillus calmette-guerin | Bacillus calmette-guerin substrain tice live antigen 50 mg/50mL | Powder, For suspensionIntravesical | Merck Sharp & Dohme LLC | 0052-0602 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 25 [iU]/.5mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4095 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 50 [iU]/mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4096 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 25 [iU]/.5mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4831 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 50 [iU]/mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4841 |
| Varivaxvaricella virus vaccine live | Varicella-zoster virus strain oka/merck live antigen 1350 [PFU]/.5mL | Injection, Powder, Lyophilized, For suspensionSubcutaneous | Merck Sharp & Dohme LLC | 0006-4827 |
| Vaxneuvancepneumococcal 15-valent conjugate vaccine crm197 protein adsorbed | Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen 2 ug/.5mL + 15 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4329 |
| Verquvovericiguat | Vericiguat 2.5 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5028 |
| Verquvovericiguat | Vericiguat 5 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5029 |